{"id":"NCT01866163","sponsor":"LEO Pharma","briefTitle":"LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris","officialTitle":"LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-06","primaryCompletion":"2013-10","completion":"2013-11","firstPosted":"2013-05-31","resultsPosted":"2016-05-09","lastUpdate":"2025-03-10"},"enrollment":426,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis Vulgaris"],"interventions":[{"type":"DRUG","name":"LEO 90100","otherNames":[]},{"type":"DRUG","name":"Vehicle","otherNames":[]}],"arms":[{"label":"LEO 90100","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this trial is to compare the efficacy of treatment with LEO 90100 to that of treatment with vehicle for up to 4 weeks in subjects with psoriasis vulgaris.","primaryOutcome":{"measure":"Treatment Success According to IGA","timeFrame":"4 weeks","effectByArm":[{"arm":"LEO 90100","deltaMin":53.3,"sd":null},{"arm":"Vehicle","deltaMin":4.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":10},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["34397196","32785881","27714595","26659941"],"seeAlso":["https://www.leopharmatrials.com/en"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":323},"commonTop":["Nasopharyngitis","Application site pain","Diarrhoea","Blood pressure increased","Nausea"]}}